Alliance Pharma (LSE:APH) Change In Inventory : £-4.1 Mil (TTM As of Jun. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Alliance Pharma Change In Inventory?

Alliance Pharma's change in inventory for the quarter that ended in Jun. 2023 was £-2.8 Mil. It means Alliance Pharma's inventory increased by £2.8 Mil from Dec. 2022 to Jun. 2023 .

Alliance Pharma's change in inventory for the fiscal year that ended in Dec. 2022 was £-2.2 Mil. It means Alliance Pharma's inventory increased by £2.2 Mil from Dec. 2021 to Dec. 2022 .

Alliance Pharma's Total Inventories for the quarter that ended in Jun. 2023 was £27.1 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Alliance Pharma's Days Inventory for the quarter that ended in Jun. 2023 was 135.76.

Inventory Turnover measures how fast the company turns over its inventory within a year. Alliance Pharma's Inventory Turnover for the quarter that ended in Jun. 2023 was 1.34.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Alliance Pharma's Inventory-to-Revenue for the quarter that ended in Jun. 2023 was 0.32.

Alliance Pharma Change In Inventory Historical Data

The historical data trend for Alliance Pharma's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alliance Pharma Change In Inventory Chart

Alliance Pharma Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Inventory

Get a 7-Day Free Trial

-4.46

2.04

-5.21

1.84

-2.21

Alliance Pharma Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Change In Inventory	Get a 7-Day Free Trial															-0.31	2.15	-0.96	-1.25	-2.81

Alliance Pharma Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-4.1 Mil.

Alliance Pharma (LSE:APH) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Alliance Pharma's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	25.691	/	34.536	*	365 / 2
	=	135.76

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Alliance Pharma's Inventory Turnover for the quarter that ended in Jun. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	34.536	/	25.691
	=	1.34

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Alliance Pharma's Inventory to Revenue for the quarter that ended in Jun. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	25.691	/	81.398
	=	0.32

Alliance Pharma Change In Inventory Related Terms

Thank you for viewing the detailed overview of Alliance Pharma's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Alliance Pharma (LSE:APH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alliance Pharma PLC (LSE:APH) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

DVL:Germany

Address

Bath Road, Avonbridge House, Chippenham, Wiltshire, GBR, SN15 2BB

Website

https://www.alliancepharmaceuticals.com

Alliance Pharma PLC is a player in the healthcare market. The company's business includes the acquisition, marketing, and distribution of consumer healthcare and pharmaceutical products. The group operates in two segments: Consumer Healthcare brands and Prescription Medicines. It generates the majority of its revenue from the Consumer Healthcare segment. Its products include Aloclair, Biodermatin, Changmin, Decapional, Effadiane, and Fazol. The company generates maximum revenue from the Kelo-cote brand. Geographically, it derives a majority of its revenue from Europe, the Middle East, and Africa (EMEA).